Liquid-based cytology (LBC) is an advanced technique for detecting abnormal cells, especially in cervical cancer screening. Unlike traditional methods, LBC provides clearer and more reliable samples.

The advantages of LBC include improved accuracy and reliability in detecting abnormal cells, such as those associated with cervical cancer. The process reduces the likelihood of inadequate or unclear samples, leading to more accurate diagnostic results. Additionally, Hospitex LBC allows for the use of the same sample for further testing, such as HPV (Human Papillomavirus) testing, without the need for additional sample collection.

Hospitex is the leading company in LBC, offering solutions that improve diagnostic accuracy and patient outcomes.